A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors

por Becerra, Carlos R., Conkling, Paul, Vogelzang, Nicholas, Wu, Hilary, Hong, Shengyan, Narwal, Rajesh, Liang, Meina, Tavakkoli, Fatemeh, Pandya, Naimish
Publicado 2014

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

por Hong, David S., Kang, Yoon-Koo, Borad, Mitesh, Sachdev, Jasgit, Ejadi, Samuel, Lim, Ho Yeong, Brenner, Andrew J., Park, Keunchil, Lee, Jae-Lyun, Kim, Tae-You, Shin, Sangjoon, Becerra, Carlos R., Falchook, Gerald, Stoudemire, Jay, Martin, Desiree, Kelnar, Kevin, Peltier, Heidi, Bonato, Vinicius, Bader, Andreas G., Smith, Susan, Kim, Sinil, O’Neill, Vincent, Beg, Muhammad S.
Publicado 2020

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors

por Gelhorn, Heather L., Tong, Sandra, McQuarrie, Kelly, Vernon, Christina, Hanlon, Jennifer, Maclaine, Grant, Lenderking, William, Ye, Xin, Speck, Rebecca M., Lackman, Richard D., Bukata, Susan V., Healey, John H., Keedy, Vicki L., Anthony, Stephen P., Wagner, Andrew J., Von Hoff, Daniel D., Singh, Arun S., Becerra, Carlos R., Hsu, Henry H., Lin, Paul S., Tap, William D.
Publicado 2016

Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring

por Shi, Yu, Gao, Weina, Lytle, Nikki K., Huang, Peiwu, Yuan, Xiao, Dann, Amanda M., Ridinger-Saison, Maya, DelGiorno, Kathleen E., Antal, Corina E., Liang, Gaoyang, Atkins, Annette R., Erikson, Galina, Sun, Huaiyu, Meisenhelder, Jill, Terenziani, Elena, Woo, Gyunghwi, Fang, Linjing, Santisakultarm, Thom P., Manor, Uri, Xu, Ruilian, Becerra, Carlos R., Borazanci, Erkut, Von Hoff, Daniel D., Grandgenett, Paul M., Hollingsworth, Michael A., Leblanc, Mathias, Umetsu, Sarah E., Collisson, Eric A., Scadeng, Miriam, Lowy, Andrew M., Donahue, Timothy R., Reya, Tannishtha, Downes, Michael, Evans, Ronald M., Wahl, Geoffrey M., Pawson, Tony, Tian, Ruijun, Hunter, Tony
Publicado 2019